{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:52:19Z","timestamp":1790797939540,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,12,19]],"date-time":"2014-12-19T00:00:00Z","timestamp":1418947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1038\/cgt.2014.64","type":"journal-article","created":{"date-parts":[[2014,12,19]],"date-time":"2014-12-19T11:16:18Z","timestamp":1418987778000},"page":"17-22","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["A novel immunocompetent murine model for replicating oncolytic adenoviral therapy"],"prefix":"10.1038","volume":"22","author":[{"given":"L","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Hedjran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Larson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G L","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,19]]},"reference":[{"key":"BFcgt201464_CR1","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/nrc948","volume":"2","author":"EA Chiocca","year":"2002","unstructured":"Chiocca EA . Oncolytic viruses. Nat Rev Cancer 2002; 2: 938\u2013950.","journal-title":"Nat Rev Cancer"},{"key":"BFcgt201464_CR2","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nm.3089","volume":"19","author":"J Heo","year":"2013","unstructured":"Heo J, Reid T, Ruo L, Breitbach CJ, Rose S, Bloomston M et al. Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer. Nat Med 2013; 19: 329\u2013336.","journal-title":"Nat Med"},{"key":"BFcgt201464_CR3","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.canlet.2007.02.002","volume":"254","author":"MJ Vaha-Koskela","year":"2007","unstructured":"Vaha-Koskela MJ, Heikkila JE, Hinkkanen AE . Oncolytic viruses in cancer therapy. Cancer Lett 2007; 254: 178\u2013216.","journal-title":"Cancer Lett"},{"key":"BFcgt201464_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1099\/0022-1317-40-1-45","volume":"40","author":"SJ Duncan","year":"1978","unstructured":"Duncan SJ, Gordon FC, Gregory DW, McPhie JL, Postlethwaite R, White R et al. Infection of mouse liver by human adenovirus type 5. J Gen Virol 1978; 40: 45\u201361.","journal-title":"J Gen Virol"},{"key":"BFcgt201464_CR5","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1073\/pnas.88.5.1651","volume":"88","author":"HS Ginsberg","year":"1991","unstructured":"Ginsberg HS, Moldawer LL, Sehgal PB, Redington M, Kilian PL, Chanock RM et al. A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia. Proc Natl Acad Sci USA 1991; 88: 1651\u20131655.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcgt201464_CR6","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1038\/mt.2012.116","volume":"20","author":"AM Young","year":"2012","unstructured":"Young AM, Archibald KM, Tookman LA, Pool A, Dudek K, Jones C et al. Failure of translation of human adenovirus mRNA in murine cancer cells can be partially overcome by L4-100K expression in vitro and in vivo. Mol Ther 2012; 20: 1676\u20131688.","journal-title":"Mol Ther"},{"key":"BFcgt201464_CR7","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1007\/s13277-012-0374-7","volume":"33","author":"H Wang","year":"2012","unstructured":"Wang H, Wei F, Zhang J, Wang F, Li H, Chen X et al. A novel immunocompetent murine tumor model for the evaluation of RCAd-enhanced RDAd transduction efficacy. Tumour Biol 2012; 33: 1245\u20131253.","journal-title":"Tumour Biol"},{"key":"BFcgt201464_CR8","first-page":"169","volume":"130","author":"MA Thomas","year":"2007","unstructured":"Thomas MA, Spencer JF, Wold WS . Use of the Syrian hamster as an animal model for oncolytic adenovirus vectors. Methods Mol Med 2007; 130: 169\u2013183.","journal-title":"Methods Mol Med"},{"key":"BFcgt201464_CR9","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/cgt.2011.41","volume":"18","author":"F Hedjran","year":"2011","unstructured":"Hedjran F, Shantanu K, Tony R . Deletion analysis of Ad5 E1a transcriptional control region: impact on tumor-selective expression of E1a and E1b. Cancer Gene Ther 2011; 18: 717\u2013723.","journal-title":"Cancer Gene Ther"},{"key":"BFcgt201464_CR10","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1038\/nprot.2006.339","volume":"1","author":"NA Franken","year":"2006","unstructured":"Franken NA, Rodermond HM, Stap J, Haveman J, van Bree C . Clonogenic assay of cells in vitro. Nat Protoc 2006; 1: 2315\u20132319.","journal-title":"Nat Protoc"},{"key":"BFcgt201464_CR11","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1089\/hum.2007.017","volume":"18","author":"S Bortolanza","year":"2007","unstructured":"Bortolanza S, Alzuguren P, Bunuales M, Qian C, Prieto J, Hernandez-Alcoceba R . Human adenovirus replicates in immunocompetent models of pancreatic cancer in Syrian hamsters. Hum Gene Ther 2007; 18: 681\u2013690.","journal-title":"Hum Gene Ther"},{"key":"BFcgt201464_CR12","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1126\/science.275.5304.1320","volume":"275","author":"JM Bergelson","year":"1997","unstructured":"Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS et al. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 1997; 275: 1320\u20131323.","journal-title":"Science"},{"key":"BFcgt201464_CR13","doi-asserted-by":"publisher","first-page":"15191","DOI":"10.1073\/pnas.261452898","volume":"98","author":"CJ Cohen","year":"2001","unstructured":"Cohen CJ, Shieh JT, Pickles RJ, Okegawa T, Hsieh JT, Bergelson JM . The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction. Proc Natl Acad Sci USA 2001; 98: 15191\u201315196.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcgt201464_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/157489207779561471","volume":"2","author":"H Deissler","year":"2007","unstructured":"Deissler H, Opalka B . Therapeutic transfer of DNA encoding adenoviral E1A. Recent Pat Anticancer Drug Discov 2007; 2: 1\u201310.","journal-title":"Recent Pat Anticancer Drug Discov"},{"key":"BFcgt201464_CR15","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3858\/emm.2008.40.4.427","volume":"40","author":"SY Han","year":"2008","unstructured":"Han SY, Lee YJ, Jung HI, Lee SW, Lim SJ, Hong SH et al. Gene transfer using liposome-complexed adenovirus seems to overcome limitations due to coxsackievirus and adenovirus receptor-deficiency of cancer cells, both in vitro and in vivo. Exp Mol Med 2008; 40: 427\u2013434.","journal-title":"Exp Mol Med"},{"key":"BFcgt201464_CR16","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/sj.cgt.7700440","volume":"9","author":"H Mizuguchi","year":"2002","unstructured":"Mizuguchi H, Hayakawa T . Enhanced antitumor effect and reduced vector dissemination with fiber-modified adenovirus vectors expressing herpes simplex virus thymidine kinase. Cancer Gene Ther 2002; 9: 236\u2013242.","journal-title":"Cancer Gene Ther"},{"key":"BFcgt201464_CR17","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1128\/JVI.74.6.2895-2899.2000","volume":"74","author":"I Ganly","year":"2000","unstructured":"Ganly I, Mautner V, Balmain A . Productive replication of human adenoviruses in mouse epidermal cells. J Virol 2000; 74: 2895\u20132899.","journal-title":"J Virol"},{"key":"BFcgt201464_CR18","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1586\/14737140.4.2.289","volume":"4","author":"EV Prochownik","year":"2004","unstructured":"Prochownik EV . c-Myc as a therapeutic target in cancer. Expert Rev Anticancer Ther 2004; 4: 289\u2013302.","journal-title":"Expert Rev Anticancer Ther"},{"key":"BFcgt201464_CR19","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/nrm1703","volume":"6","author":"S Adhikary","year":"2005","unstructured":"Adhikary S, Eilers M . Transcriptional regulation and transformation by Myc proteins. Nat Rev Mol Cell Biol 2005; 6: 635\u2013645.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFcgt201464_CR20","first-page":"89","volume":"43","author":"D Kirn","year":"2003","unstructured":"Kirn D . Oncolytic virotherapy as a novel treatment platform for cancer. Ernst Schering Res Found Workshop 2003; 43: 89\u2013105.","journal-title":"Ernst Schering Res Found Workshop"},{"key":"BFcgt201464_CR21","first-page":"119","volume":"199","author":"LA Lucher","year":"1995","unstructured":"Lucher LA . Abortive adenovirus infection and host range determinants. Curr Top Microbiol Immunol 1995; 199: 119\u2013152.","journal-title":"Curr Top Microbiol Immunol"},{"key":"BFcgt201464_CR22","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/cgt.2012.41","volume":"19","author":"Z Zhang","year":"2012","unstructured":"Zhang Z, Hu Z, Gupta J, Krimmel JD, Gerseny HM, Berg AF et al. Intravenous administration of adenoviruses targeting transforming growth factor beta signaling inhibits established bone metastases in 4T1 mouse mammary tumor model in an immunocompetent syngeneic host. Cancer Gene Ther 2012; 19: 630\u2013636.","journal-title":"Cancer Gene Ther"},{"key":"BFcgt201464_CR23","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/S1525-0016(03)00199-0","volume":"8","author":"G Hallden","year":"2003","unstructured":"Hallden G, Hill R, Wang Y, Anand A, Liu TC, Lemoine NR et al. Novel immunocompetent murine tumor models for the assessment of replication-competent oncolytic adenovirus efficacy. Mol Ther 2003; 8: 412\u2013424.","journal-title":"Mol Ther"},{"key":"BFcgt201464_CR24","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/cgt.2009.6","volume":"16","author":"B Ying","year":"2009","unstructured":"Ying B, Toth K, Spencer JF, Meyer J, Tollefson AE, Patra D et al. INGN 007, an oncolytic adenovirus vector, replicates in Syrian hamsters but not mice: comparison of biodistribution studies. Cancer Gene Ther 2009; 16: 625\u2013637.","journal-title":"Cancer Gene Ther"},{"key":"BFcgt201464_CR25","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1158\/0008-5472.CAN-05-3497","volume":"66","author":"MA Thomas","year":"2006","unstructured":"Thomas MA, Spencer JF, La Regina MC, Dhar D, Tollefson AE, Toth K et al. Syrian hamster as a permissive immunocompetent animal model for the study of oncolytic adenovirus vectors. Cancer Res 2006; 66: 1270\u20131276.","journal-title":"Cancer Res"},{"key":"BFcgt201464_CR26","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1089\/hum.2005.16.139","volume":"16","author":"K Toth","year":"2005","unstructured":"Toth K, Spencer JF, Tollefson AE, Kuppuswamy M, Doronin K, Lichtenstein DL et al. Cotton rat tumor model for the evaluation of oncolytic adenoviruses. Hum Gene Ther 2005; 16: 139\u2013146.","journal-title":"Hum Gene Ther"},{"key":"BFcgt201464_CR27","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.virol.2007.07.022","volume":"369","author":"JC Steel","year":"2007","unstructured":"Steel JC, Morrison BJ, Mannan P, Abu-Asab MS, Wildner O, Miles BK et al. Immunocompetent syngeneic cotton rat tumor models for the assessment of replication-competent oncolytic adenovirus. Virology 2007; 369: 131\u2013142.","journal-title":"Virology"},{"key":"BFcgt201464_CR28","doi-asserted-by":"publisher","first-page":"3549","DOI":"10.1128\/JVI.80.7.3549-3558.2006","volume":"80","author":"C Jogler","year":"2006","unstructured":"Jogler C, Hoffmann D, Theegarten D, Grunwald T, Uberla K, Wildner O . Replication properties of human adenovirus in vivo and in cultures of primary cells from different animal species. J Virol 2006; 80: 3549\u20133558.","journal-title":"J Virol"},{"key":"BFcgt201464_CR29","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1038\/35074129","volume":"410","author":"L Johnson","year":"2001","unstructured":"Johnson L, Mercer K, Greenbaum D, Bronson RT, Crowley D, Tuveson DA et al. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature 2001; 410: 1111\u20131116.","journal-title":"Nature"},{"key":"BFcgt201464_CR30","doi-asserted-by":"publisher","first-page":"4198","DOI":"10.1158\/0008-5472.CAN-05-3842","volume":"66","author":"M Wislez","year":"2006","unstructured":"Wislez M, Fujimoto N, Izzo JG, Hanna AE, Cody DD, Langley RR et al. High expression of ligands for chemokine receptor CXCR2 in alveolar epithelial neoplasia induced by oncogenic kras. Cancer Res 2006; 66: 4198\u20134207.","journal-title":"Cancer Res"},{"key":"BFcgt201464_CR31","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.1158\/0008-5472.CAN-04-4420","volume":"65","author":"M Wislez","year":"2005","unstructured":"Wislez M, Spencer ML, Izzo JG, Juroske DM, Balhara K, Cody DD et al. Inhibition of mammalian target of rapamycin reverses alveolar epithelial neoplasia induced by oncogenic K-ras. Cancer Res 2005; 65: 3226\u20133235.","journal-title":"Cancer Res"},{"key":"BFcgt201464_CR32","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1158\/1535-7163.MCT-12-0933","volume":"12","author":"T Ma","year":"2013","unstructured":"Ma T, Galimberti F, Erkmen CP, Memoli V, Chinyengetere F, Sempere L et al. Comparing histone deacetylase inhibitor responses in genetically engineered mouse lung cancer models and a window of opportunity trial in patients with lung cancer. Mol Cancer Ther 2013; 12: 1545\u20131555.","journal-title":"Mol Cancer Ther"},{"key":"BFcgt201464_CR33","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1093\/carcin\/bgp229","volume":"30","author":"SJ Moghaddam","year":"2009","unstructured":"Moghaddam SJ, Barta P, Mirabolfathinejad SG, Ammar-Aouchiche Z, Garza NT, Vo TT et al. Curcumin inhibits COPD-like airway inflammation and lung cancer progression in mice. Carcinogenesis 2009; 30: 1949\u20131956.","journal-title":"Carcinogenesis"},{"key":"BFcgt201464_CR34","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/ng2003","volume":"39","author":"MS Kumar","year":"2007","unstructured":"Kumar MS, Lu J, Mercer KL, Golub TR, Jacks T . Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet 2007; 39: 673\u2013677.","journal-title":"Nat Genet"},{"key":"BFcgt201464_CR35","doi-asserted-by":"publisher","first-page":"7237","DOI":"10.1158\/0008-5472.CAN-08-1529","volume":"68","author":"L Zhong","year":"2008","unstructured":"Zhong L, Roybal J, Chaerkady R, Zhang W, Choi K, Alvarez CA et al. Identification of secreted proteins that mediate cell-cell interactions in an in vitro model of the lung cancer microenvironment. Cancer Res 2008; 68: 7237\u20137245.","journal-title":"Cancer Res"},{"key":"BFcgt201464_CR36","doi-asserted-by":"publisher","first-page":"5763","DOI":"10.1200\/JCO.2009.24.3675","volume":"27","author":"NN Senzer","year":"2009","unstructured":"Senzer NN, Kaufman HL, Amatruda T, Nemunaitis M, Reid T, Daniels G et al. Phase II clinical trial of a granulocyte-macrophage colony-stimulating factor-encoding, second-generation oncolytic herpesvirus in patients with unresectable metastatic melanoma. J Clin Oncol 2009; 27: 5763\u20135771.","journal-title":"J Clin Oncol"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/cgt201464.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cgt201464","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cgt201464.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:14:07Z","timestamp":1684415647000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cgt201464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,19]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["BFcgt201464"],"URL":"https:\/\/doi.org\/10.1038\/cgt.2014.64","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,19]]},"assertion":[{"value":"2 July 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}